Related references
Note: Only part of the references are listed.Leishmaniasis and various immunotherapeutic approaches
Y. Taslimi et al.
PARASITOLOGY (2018)
Using focused pharmacovigilance for ensuring patient safety against antileishmanial drugs in Bangladesh's National Kala-azar Elimination Programme
Md Sakhawat Hossain et al.
INFECTIOUS DISEASES OF POVERTY (2018)
Allergic reactions to meglumine antimoniate while treating cutaneous leishmaniasis
A. Brasileiro et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2017)
Short-Course Treatment Regimen of Indian Visceral Leishmaniasis with an Indian Liposomal Amphotericin B Preparation (Fungisome™)
Rama P. Goswami et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2016)
Current clinical, laboratory, and treatment outcome characteristics of visceral leishmaniasis: results from a seven-year retrospective study in Greece
Sarah P. Georgiadou et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2015)
Five-Year Retrospective Italian Multicenter Study of Visceral Leishmaniasis Treatment
Francesco Di Masi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Hepatotoxicity of Pentavalent Antimonial Drug: Possible Role of Residual Sb(III) and Protective Effect of Ascorbic Acid
Kelly C. Kato et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Mortality and Case Fatality Due to Visceral Leishmaniasis in Brazil: A Nationwide Analysis of Epidemiology, Trends and Spatial Patterns
Francisco Rogerlandio Martins-Melo et al.
PLOS ONE (2014)
American Visceral Leishmaniasis: Factors Associated with Lethality in the State of Sao Paulo, Brazil
Geraldine Madalosso et al.
JOURNAL OF TROPICAL MEDICINE (2012)
Leishmaniasis impact and treatment access
M. den Boer et al.
CLINICAL MICROBIOLOGY AND INFECTION (2011)
Recent advances in leishmaniasis treatment
Tatiana S. Tiuman et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2011)
Antimony Toxicity
Shyam Sundar et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2010)
Severe adverse reactions to meglumine antimoniate in the treatment of visceral leishmaniasis: a report of 13 cases in the southwestern region of Brazil
Ana Lucia Lyrio de Oliveira et al.
TROPICAL DOCTOR (2009)
Glucantime((R)) injection: benefit versus toxicity
A Masmoudi et al.
MEDECINE ET MALADIES INFECTIEUSES (2005)
Share Paper
